Bioprosthetic valve fracture: a practical guide

Ann Cardiothorac Surg. 2021 Sep;10(5):564-570. doi: 10.21037/acs-2021-tviv-25.


Valve-in-valve transcatheter aortic valve replacement (VIV TAVR) is currently indicated for the treatment of failed surgical tissue valves in patients determined to be at high surgical risk for re-operative surgical valve replacement. VIV TAVR, however, often results in suboptimal expansion of the transcatheter heart valve (THV) and can result in patient-prosthesis mismatch (PPM), particularly in small surgical valves. Bioprosthetic valve fracture (BVF) and bioprosthetic valve remodeling (BVR) can facilitate VIV TAVR by optimally expanding the THV and reducing the residual transvalvular gradient by utilizing a high-pressure inflation with a non-compliant balloon to either fracture or stretch the surgical valve ring, respectively. This article, along with the supplemental video, will provide patient selection, procedural planning and technical insights for performing BVF and BVR.

Keywords: Surgical aortic valve replacement; bioprosthetic valve fracture (BVF); replacement; transcatheter aortic valve; valve in valve.

Publication types

  • Review